Case report: Use of

68 Ga-DOTATATE-PET SSTR2 expression atypical meningioma case report complex meningioma disease

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 11 08 2022
accepted: 26 09 2022
entrez: 31 10 2022
pubmed: 1 11 2022
medline: 1 11 2022
Statut: epublish

Résumé

Currently, contrast-enhanced MRI is the method of choice for treatment planning and follow-up in patients with meningioma. However, positron emission tomography (PET) imaging of somatostatin receptor subtype 2 (SSTR2) expression using

Identifiants

pubmed: 36313670
doi: 10.3389/fonc.2022.1017339
pmc: PMC9596965
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1017339

Informations de copyright

Copyright © 2022 Meißner, von Spreckelsen, Al Shughri, Brunn, Fuertjes, Schlamann, Schmidt, Dietlein, Rueß, Ruge, Galldiks and Goldbrunner.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Nucl Med. 2017 Oct;58(10):1580-1587
pubmed: 28450556
J Neurosurg. 2015 Jan;122(1):4-23
pubmed: 25343186
Neuro Oncol. 2017 Nov 29;19(12):1576-1587
pubmed: 28605532
Lancet Neurol. 2006 Dec;5(12):1045-54
pubmed: 17110285
Radiol Imaging Cancer. 2022 Mar;4(2):e210067
pubmed: 35275019
Radiat Oncol. 2021 Aug 16;16(1):151
pubmed: 34399805
Cancer. 2003 Oct 1;98(7):1473-82
pubmed: 14508835
J Nucl Med. 2015 Jan;56(1):3-8
pubmed: 25500828
Int J Clin Exp Pathol. 2015 Oct 01;8(10):13185-92
pubmed: 26722517
Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):868-871
pubmed: 35772444
AJR Am J Roentgenol. 2018 Aug;211(2):267-277
pubmed: 29975116
Neuro Oncol. 2021 Nov 2;23(11):1821-1834
pubmed: 34181733
Neurosurg Focus. 2021 Jan;50(1):E6
pubmed: 33386007
Acta Neurochir (Wien). 2018 Aug;160(8):1539-1546
pubmed: 29858948
Clin Nucl Med. 2021 Sep 1;46(9):e464-e465
pubmed: 33826577
Am J Transl Res. 2021 Oct 15;13(10):11223-11234
pubmed: 34786053
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1409-15
pubmed: 22669255
J Nucl Med Technol. 2022 Aug 30;:
pubmed: 36041874
J Neuroimaging. 2019 Sep;29(5):650-656
pubmed: 31107591
Front Oncol. 2018 Oct 16;8:454
pubmed: 30386741
J Nucl Med. 2015 Mar;56(3):347-53
pubmed: 25635133
J Clin Endocrinol Metab. 1986 Aug;63(2):433-8
pubmed: 3013920
J Neurosurg. 1994 Feb;80(2):195-201
pubmed: 8283256
Eur J Nucl Med. 1998 Jul;25(7):675-86
pubmed: 9662588

Auteurs

Anna-Katharina Meißner (AK)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Niklas von Spreckelsen (N)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Abdulkader Al Shughri (A)

Department of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Anna Brunn (A)

Department of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Gina Fuertjes (G)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Marc Schlamann (M)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne and, Duesseldorf, Germany.

Matthias Schmidt (M)

Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne and, Duesseldorf, Germany.
Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Markus Dietlein (M)

Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne and, Duesseldorf, Germany.
Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Daniel Rueß (D)

Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne and, Duesseldorf, Germany.
Department of Stereotaxy and Functional Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Maximilian I Ruge (MI)

Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne and, Duesseldorf, Germany.
Department of Stereotaxy and Functional Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Norbert Galldiks (N)

Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne and, Duesseldorf, Germany.
Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany.

Roland Goldbrunner (R)

Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne and, Duesseldorf, Germany.

Classifications MeSH